Veritas Asset Management LLP
Institutional investor · Portfolio as of Q1 2020
Top Holdings32 positions
CHARTER COMMUNICATIONS INC N | 3.3M | $1.4B | 11.4% | $349.34 | +24.90% | 5 qtrssince 2019-Q1 | Increased 65 |
Alphabet Inc. | 1.2M | $1.4B | 10.9% | $57.39 | +0.28% | 5 qtrssince 2019-Q1 | Increased 65 |
Meta Platforms Inc | 5.4M | $905.7M | 7.2% | $169.71 | -2.89% | 5 qtrssince 2019-Q1 | Increased 69 |
CIGNA CORP NEW | 4.2M | $746.7M | 5.9% | $155.22 | +5.06% | 5 qtrssince 2019-Q1 | Increased 83 |
BAXTER INTL INC | 9M | $726.9M | 5.8% | $72.21 | +1.40% | 5 qtrssince 2019-Q1 | Increased 76 |
| 3.3M | $723.3M | 5.7% | — | — | 4 qtrssince 2019-Q2 | Increased 66 | |
ALTICE USA INC | 29.5M | $656.6M | 5.2% | $25.73 | -10.94% | 2 qtrssince 2019-Q4 | Increased 85 |
Intercontinental Exchange Inc | 8.1M | $655M | 5.2% | $77.26 | -3.84% | 4 qtrssince 2019-Q2 | Increased 87 |
UnitedHealth Group Inc. | 2.6M | $652.8M | 5.2% | $219.77 | +1.34% | 5 qtrssince 2019-Q1 | Increased 62 |
CVS HEALTH CORP | 10.2M | $607.3M | 4.8% | $45.46 | +5.83% | 5 qtrssince 2019-Q1 | Increased 75 |
ALIBABA GROUP HLDG LTD | 3M | $575.9M | 4.6% | $177.90 | +2.11% | 5 qtrssince 2019-Q1 | Increased 94 |
MasterCard Incorporated | 2.3M | $549.6M | 4.4% | $232.73 | 0.00% | 1 qtr | New 88 |
RAYTHEON CO | 4.2M | $544.6M | 4.3% | — | — | 1 qtr | New 88 |
Thermo Fisher Scientific Inc | 1.8M | $520.8M | 4.1% | $268.25 | +3.89% | 5 qtrssince 2019-Q1 | Decreased 0 |
Philip Morris International Inc. | 6.5M | $470.9M | 3.7% | $60.64 | -12.06% | 5 qtrssince 2019-Q1 | Decreased 0 |
| 1.5M | $409.1M | 3.2% | — | — | — | Increased 66 | |
Abbott Laboratories | 5M | $398.4M | 3.2% | $71.31 | 0.00% | 1 qtr | New 87 |
BECTON DICKINSON & CO | 1.5M | $343M | 2.7% | $157.88 | 0.00% | 1 qtr | New 81 |
TAL EDUCATION GROUP | 1.5M | $79.9M | 0.6% | $52.00 | 0.00% | 1 qtr | New 59 |
SEA LTD SPONSORD ADS | 1M | $45.9M | 0.4% | $44.46 | 0.00% | 1 qtr | New 49 |
Veritas Asset Management LLP manages $12.6B across 32 positions as of Q1 2020. Top holdings: CHTR (11.4%), GOOGL (10.9%), META (7.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 5/5.0.
Active quarter - 10 new positions, 1 exits, 15 increased. Top move: BABA (INCREASED, conviction 94). Portfolio: $12.6B across 32 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR